Trifecta Capital Advisors, LLC Zoetis Inc. Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 914 shares of ZTS stock, worth $161,540. This represents 0.04% of its overall portfolio holdings.
Number of Shares
914
Previous 914
-0.0%
Holding current value
$161,540
Previous $158 Million
12.7%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding ZTS
# of Institutions
1,957Shares Held
412MCall Options Held
1.02MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.29 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.51 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.5 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.83 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.72 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $82.7B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...